Final formulation

It is necessary to undertake a series of adjustments to achieve the target composition. If the osmolality has to be increased by replacing maltodextrin with monosaccharides then additional salts will be required to maintain electrolyte levels these in turn will increase the osmolality and require a further reduction in maltodextrin. Table 13.7 indicates how the components of a typical isotonic sports drink contribute to its osmolality. 

---

The development of freeze-drying for the production of blood derivatives was pioneered during World War II (96,97). It is used for the stabilization of coagulation factor (98,99) and intravenous immunoglobulin (IgG iv) products, and also for the removal of ethanol from intramuscular immunoglobulin (IgG im) solutions prior to their final formulation (Fig. 2). 

Pesticides. Many pesticides are highly concentrated and are in a physical form requiring further treatment to permit effective appHcation. Typically carriers or diluents are used (see Insectcontroltechnology). Although these materials are usually considered inert, they have a vital bearing on the potency and efficiency of the dust or spray because the carrier may consist of up to 99% of the final formulation. The physical properties of the carrier or diluent are of great importance in the uniform dispersion, the retention of pesticide by the plant, and in the preservation of the toxicity of the pesticide. The carrier must not, for example, serve as a catalyst for any reaction of the pesticide that would alter its potency. 

Although in many cases an enantiopure drug can be safer than the racemate, the advantages are clear. The final formulation of the drug product could be reduced inhalf, potential side effects could be minimized, and the resulting pharmokinetic and pharmacodynamic studies could clearly determine the efficacy of the active pharmaceutical ingredient (API) [21]. 

Microbial insecticides are very complex materials in their final formulation, because they are produced by fermentation of a variety of natural products. For growth, the bacteria must be provided with a source of carbon, nitrogen, and mineral salts. Sufficient nutrient is provided to take the strain of choice through its life cycle to complete sporulation with concomitant parasporal body formation. Certain crystalliferous bacilli require sources of preformed vitamins and/or amino acids for growth. Media for growing these bacilli may vary from completely soluble, defined formulations, usable for bench scale work, to rich media containing insoluble constituents for production situations (10,27). Complex natural materials such as cottonseed, soybean, and fish meal are commonly used. In fact, one such commercial production method (25) is based on use of a semisolid medium, a bran, which becomes part of the final product. 

The earlier work of Miller (35), Outright (37), and Brady (5) on nonmedicated implants provided an excellent basis for further studies on specific controlled release formulations such as the determination of the biodegradation rates of lactide/glycolide drug-loaded microspheres (38). Those studies were done with l c-iabeled polymers produced from DL-lactic acid and glycolide. The final formulations tested in rats were microspheres loaded with H-labeled steroid and polymer as the matrix. The microspheres were administered intramuscularly and animals were serially sacrificed over a period of about a year. 

When formulating antibacterial preparations it is imperative to realize that the properties of the base may seriously modify the antibacterial activity of the medicament It is quite useless to formulate a well-proven antiseptic into an otherwise elegant pharmaceutical preparation without determining if the final formulation is, itself, an effective antibaeterial agent. 

Food additives (like color additives) can be added at various processing stages, but the additions are commonly made at the latest production stage before final marketing to ensure optimal functionality of the additive in the product as sold. Residues of additives used at earlier production stages may be present still in the final formulation. However, if they do not have further functions at that stage, they are considered process aids (to help preparation but without technological effects in the finished product) and are not indicated on labels. Some additives also decompose over time so that the levels present at the end of shelf life may be quite low. Several techniques and information sources can be used to assess contamination levels of chemicals ... 

Thickeners and binders such as acacia, agar, starch, sodium alig-nate, gelatin, methyl cellulose, bentonite, and silica are used to improve product stability and enhance the convenience of the administration of a liquid formulation. Surface-active agents, colors, flavors and preservatives may also be used in the final formulation (Garcia et ah. Bioseparation Process Science, Blackwell Science, Malden, Mass., 1999, p. 374). 

The expression in the square brackets is exactly the formation energy of the Pt bulk oxide out of bulk platinum and molecular O2, which can easily be evaluated by DFT calculations [Jacob, 2007b]. Together with the experimental value for AGq, we can finally formulate the following stabUity ranges at which the three known Pt bulk oxides are thermodynamically stable ... 

After performing a nutrition assessment and estimating nutritional requirements, determine the optimal route to provide specialized nutrition support (e.g., oral, enteral, or parenteral). If PN is deemed necessary, venous access (i.e., peripheral or central see below) for PN infusion must be obtained. Finally, formulate a PN prescription, and administer PN according to proper safety guidelines. 

All aqueous solutions, intermediate products and final formulations should be well protected. Many problems can be avoided if care is taken to ensure that, wherever possible, the biocide is the first raw material to be added to the water at the outset of production. In this way the water is sterilised and raw materials, even if they have a low level of infection, do not become problematic. 

Real-Time FTIR. For our IR studies, we utilized a stoichiometrically equivalent amount of a trifunctional thiol, trimethylolpropane tris(2-mercaptoacetate), with a difunctional allyl, trimethylolpropane diallyl ether. The thiols were protected from oxidative polymerization by the addition of hydroquinone. The monomers and hydroquinone were purchased from Aldrich Chemicals and were used as received. This formulation was mixed for five minutes and then a commercial photoinitiator, Esacure TZT (Sartomer Inc.), which contained a blend of methyl benzophenones, was added at a level of 1.0% by weight of monomers to the formulation. Stirring was maintained for a further five minutes following the addition of the photoinitiator. The final formulation contained 2.0% by weight of hydroquinone. The samples were prepared prior to each experiment in order to ensure reproducibility of sample history. 

For the skin, this scale is used in the primary dermal irritation test, which is performed for those agents that are to be administered to patients by application to the skin. As with all local tolerance tests, it is essential that the material be evaluated in condition of use, that is, in the final formulated form, applied to test animals in the same manner that the agent is to be used clinically. 

Irritation. Tissue irritation upon injection, and the accompanying damage and pain, is a concern that must be addressed for the final formulation, which is to be either tested in humans or marketed, rather than for the active ingredient. This is because most irritation factors are either due to or influenced by aspects of formulation design (see Avis, 1985, for more information or parenteral preparations). These factors are not independent of the route (TV, IM, or SC) that will be used and, in fact (as discussed later), are part of the basis for selecting between the various routes. 

The answer to all these questions defines the design criteria for the specific product. In the end, the final formulation will be a compromise between the criteria mentioned above. When the design criteria have been settled, the actual formulation can commence. Not surprisingly, industrial paints or coatings need to be more versatile than household paints. Their prime purpose is to provide protection from the environment. In the case of a chemically active antifouling paint this means, overall, that it must ... 

Analytical scientists will provide support for many of the activities in a biopharmaceutical company. They are responsible for characterizing the molecules in development, establishing and performing assays that aid in optimization and reproducibility of the purification schemes, and optimizing conditions for fermentation or cell culture to include product yields. Some of the characterization techniques will eventually be used in quality control to establish purity, potency, and identity of the final formulation. The techniques described here should provide the beginning of a palette from which to develop analytical solutions. 

Figure 12.1 Clearance of small-molecule impurities from process buffers in a formulated protein product. Trace A the NMR spectrum of a control sample containing a mixture of three components (succinate, tetraethylammonium, and tetramethylammonium) in the final formulation buffer (sodium acetate). These three components were used in the recovery process for a biopharmaceutical product. Traces B and D the proton NMR spectra of the formulated protein product. No TEA or TMA were detected, but a small amount of succinate was observed in this sample. Traces C and E the proton NMR spectra of a formulated protein product spiked with 10 jag/ml of succinate, TEA, and TMA. Traces D and E were recorded with CPMG spin-echo method to reduce the protein signals. The reduction of NMR signals from the protein allows for better observation of the small-molecule signals.

Another way to detect small molecules in the final formulated protein product without the interference from the protein signals is to remove the protein by ultrafiltration. Figure 12.4 compares a section of the proton NMR spectra of a biopharmaceutical protein product before (upper spectrum) and after (bottom spectrum) the protein was removed by ultrafiltering the sample with a Centricon-10 (Millipore Corp, Bedford, MA). Removing protein results in a flatter baseline (bottom spectrum). If small molecules are present in a protein sample, the removal of the protein may allow for unobstructed detection of the small molecules. In this case, a small amount of acetate ( 1 pg/rnl) is detected in the sample [bottom trace, Figure 12.4], Figure 12.5 shows that spikes of 10 p.g/ml of acetate and MES into the protein sample are fully recovered after the ultrafiltration to remove the protein. This example demonstrates that the interference of protein with the detection and quantitation of small-molecule impurities in a formulated protein product can be effectively eliminated by ultrafiltration. 

Pharmaceutics work should be completed, including sfabilify sfudies on fhe final formulation that can be utilized worldwide. 

---